World / Science & Health May 4, 2023
First RSV vaccine caps 60-year search to stem pervasive lung illness
by Suzi Ring
The U.S. Food and Drug Administration cleared GSK’s shot against respiratory syncytial virus on Wednesday. The product will go on sale in the coming weeks for older adults.
